Evoked Compound Action Potentials for Parkinson's Disease (eCAP-PD) Study

Go Back to All Clinical Trials

Evoked Compound Action Potentials for Parkinson's Disease (eCAP-PD) Study

Brief description of study

The purpose of this research is to see whether the study device, the Evoke® SCS System, is safe and works to treat Parkinson’s disease symptoms. The Evoke Spinal Cord Stimulator is FDA approved for and routinely used to treat chronic pain, but it has not been tested to know whether it helps treat Parkinson’s Disease symptoms.

Clinical Study Identifier: s24-00144

ClinicalTrials.gov Identifier: NCT06080022

Principal Investigator: Michael H. Pourfar.

Other Investigator: Alon Mogilner.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies